TruthArchive.ai - Related Video Feed

Speaker 0 warns that the g n one mutations are very alarming because the mutations are no longer restricted to spike protein, which indicates enhanced activity of CTLs to diminish viral infectiousness, and that CTL activity is responsible for the decline of T cells that in fact boost the non neutralizing antibodies that prevent virulence. He says that this is why he has been predicting that evolution would inevitably lead to the emergence of a highly virulent variant that would cause waves of hospitalization and severe disease in highly vaccinated countries. Speaker 1 acknowledges and asks for quantification, wondering if this will lead to more deaths and how many, seeking precise figures. Speaker 0 refrains from giving specific numbers, stating that it is not due to fear of figures but because it is unprecedented. He says what we will see is something completely, completely unprecedented in terms of the magnitude of the wave of morbidity and, unfortunately, mortality that we will see. Speaker 1 presses for a multiplier (10x, 5x, 3x, 20x). Speaker 0 responds that in highly vaccinated populations, depending on age, vaccine coverage, and vaccination speed, we might be dealing with serious decimation of the population, with some populations potentially seeing up to thirty to forty percent.

We isolated coronaviruses from animals in the past to understand their threat to other species by culturing them on different cell types. This process, known as gain of function, involves enriching mutants that can infect new species. The speaker emphasizes that mass vaccination in humans is a significant gain of function experiment, leading to virus evolution. This real-world experiment involves constant virus changes due to human-to-human transmission under vaccine pressure.

In the near future, there will be mandatory vaccination, potentially causing a flu pandemic. If there are widespread deaths from these vaccinations, there may be a rebellion against vaccines.

Now that we're coming out of the pandemic, the issue of variants will mainly be discussed by specialists. They will talk about the impact of these variants in conferences. Currently, the planned vaccination covers all variants. And does vaccination limit the emergence of new variants? Absolutely, by reducing the number of affected individuals. It decreases the portion of the population where the virus can multiply and mutate, thus leading to new variants. So, vaccination is absolutely essential to control the situation.

The phylogenetic tree on nextstrain.org shows the progression of COVID-19 variants. Initially, there was the original strain from Wuhan in January 2020, followed by a few small mutations. As vaccination efforts increased, more variants like Delta and Omicron emerged. This contradicts Fauci's statement that vaccinated individuals would be a dead end for the virus. It's unclear if Omicron, which has lower virulence, will cause future problems for vaccinated or unvaccinated people. The concern is that the vaccination program is not only ineffective at stopping infection but also contributing to the development of immune system-evading variants.

The speaker discusses a hypothesis regarding the connection between COVID-19 and the vaccines. They mention that SARS-CoV-2 was a product of dual-use research and that the spike protein in the vaccines is also from SARS-CoV-2. They explain that some people who received multiple vaccine shots experienced an interesting effect called IgG 4, which turns down the immune response. The speaker suggests that if the vaccines induce this attenuation signal, it could potentially make a population less reactive to a pathogen. They note that the Chinese did not use mRNA vaccines like other countries, which could mean that populations are now different in terms of their immune response. The speaker acknowledges that this is only a hypothesis and lacks evidence. They also express concerns about the widespread vaccination efforts and the unknown long-term impacts.

YouTube censorship and the use of genetic vaccines are discussed in this video. The speaker, a researcher in biological and medical sciences, claims that genetic vaccines can lead to the emergence of recombinant viruses. They explain that recombinant viruses are a mix of genetic material from two parental viruses, but co-infection with two viruses is unlikely. The speaker also argues that mass vaccination with genetic vaccines can contribute to the selection of variant viruses. They personally choose not to get vaccinated against COVID-19, believing it is the responsibility of non-vulnerable individuals to refrain from vaccination. They suggest that convincing older individuals to get vaccinated is difficult due to a lack of persuasive arguments.

The speaker criticizes the mass vaccination campaign, claiming that it has led to an increase in COVID-19 cases and deaths, particularly among young people with blood clots. They argue that the variants of the virus are a result of the vaccinations, as the antibodies produced by the vaccine create a selection pressure that leads to the emergence of new variants. The speaker also suggests that antibodies can actually enhance the infection instead of providing protection. They conclude that vaccinating during an ongoing epidemic is a mistake.

The video discusses the effectiveness of COVID-19 vaccines and their impact on the spread of the virus. The speaker argues that the vaccines are actually causing more harm by increasing people's vulnerability to the disease. They present a study from Cleveland, Ohio, which shows that the more vaccine doses a person receives, the more likely they are to contract and spread COVID-19. The speaker also mentions data from New South Wales, Australia, indicating that the more vaccine doses a person has, the higher their chances of severe illness and hospitalization. They conclude that the vaccines are functioning as "anti-vaccines" and making people more susceptible to the virus. However, another speaker emphasizes the importance of vaccination in preventing severe illness and death. They encourage people to get vaccinated and highlight the potential restrictions for those who remain unvaccinated.

The speakers discuss the expected mutation of the virus and the impact of vaccination. They acknowledge that as people become immunized, the virus will try to find ways to evade the vaccine. The more people are vaccinated, the more pressure is put on the virus to mutate. Some virologists warn that vaccinating the entire world with narrow immunity could lead to the emergence of superbugs. They urge for the use of the right vaccine in the right place and caution against mass vaccination during a pandemic. They argue that current interventions and mass vaccination may be causing more harm than good, driving the emergence of more infectious and potentially lethal variants.

The speaker discusses signals of transgenerational harm, clarifying they are not referring to transgender issues but harms that span generations. They cite CDC data to support a claim that, beginning right after mass vaccination of childbearing-age women in early 2021, there is a statistically significant inflection point in infant mortality. They state that infant mortality rates had been steadily decreasing for thirty years, but in 2021, after mass vaccination, the rate “shoots right up,” and it “hasn't gone down since.” As of 2025, they assert, babies are dying at seventy-seven percent excess, with Mississippi reportedly declaring a state of emergency over the situation. The speaker further claims that mothers are not taking the shots anymore. They suggest that some of the genetic material from the vaccination appears to integrate into the body and may be passed on, describing it as a legacy effect. They emphasize that most people took the shots in 2021, and express concern that there could be effects through the generations as a result.

The virus prefers to infect unvaccinated individuals because it is easier for them to get infected. It also adapts to its environment, so variants that can infect unvaccinated people more quickly will emerge. This could potentially lead to the emergence of variants that are more troublesome for unvaccinated individuals.

The video discusses a study on the Omicron variant of SARS-CoV-2, which suggests that the mutations observed in the variant may not be natural. The researchers found a systematic pattern in the mutations, where certain mutations were removed and then reintroduced in a stepwise manner. This led them to propose the possibility of artificial creation of the variant. The video highlights that this assertion is significant and should be considered in discussions about the origins of Omicron. The study's findings indicate that all 400 variants of Omicron may have been created in a lab rather than evolving naturally. The researchers emphasize the need for further debate and investigation into the origins of the variant.

The transcript argues that more dangerous SARS-CoV-2 variants could arise by creating biological niches for variants and through VADES, with the speaker stating that “viral immune escape threatens to play a catastrophic role in the COVID mass vaccinated world.” It describes the virus as originally relatively harmless with a very low death percentage for healthy young people, potentially evolving into a seasonal virus with an even lower death percentage. However, it is claimed that mass vaccination could disturb this natural progression and cause resistant, and potentially more dangerous and more contagious variants by creating biological niches for those variants. The speaker asserts a correlation between the rise of variants and the increase of vaccinations, stating that “the rise of variants correlates with the increase of vaccinations.” In this context, viral immune escape is mentioned, and antibody-dependent enhancement (ADE) is noted as a phenomenon that can worsen disease; the speaker notes that ADE is known to be an issue with coronaviruses and was an issue in animal trials for SARS vaccines, and is associated with SARS and severe COVID itself. The claim is made that as more vaccines and different vaccine types are administered, and as more COVID variants succeed, the ADE risk increases. According to the speaker, given these considerations, the worldwide mass vaccination agenda is described as a “haste and rush agenda,” very dangerous and destined to become a failure. The speaker questions whether “the mass vaccination induced immune escape COVID killing waves and vades” are coming for the COVID vaccinated. To illustrate the situation, the transcript cites a series of record-high stretcher occupancy values in Quebec, across several dates in 2024: 07/08/2024 – 2,319; 07/08/2024 – 2,370; 08/06/2024 – 2,384; 08/27/2024 – 2,395; 08/24/24 – 2,412; 09/03/2024 – 2,444. The source cited is Sourcetumia.org, with a request to “please like and follow.”

A virologist warns of potential mass deaths among COVID-19 vaccinated individuals due to compromised immune systems and new variants. He criticizes mass vaccination as a dangerous experiment, likening it to gain-of-function research. The virologist accuses a COVID cartel of profiting from the situation and warns of long-term health issues like cancer and long COVID. The speaker urges viewers to prepare with an emergency kit containing antibiotics and antivirals. The virologist's concerns about the vaccine's effects are highlighted, with personal anecdotes of vaccine-related health problems. The video concludes with a promotion for the emergency kit.

The virus prefers to infect unvaccinated individuals because it is easier for them to get infected. It adapts and the variants that can infect unvaccinated people more quickly will emerge. This may lead to the emergence of variants that are more troublesome for unvaccinated individuals.

Robert F. Kennedy Jr.: Hi, it's Robert F. Kennedy Jr. here, your HHS secretary. At HHS, we have a division called the Biomedical Advanced Research and Development Authority, or BARDA. BARDA drives some of our most advanced scientific research. It funds developments of vaccines, drugs, diagnostics, and other tools to fight emerging diseases and national health threats. Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Let me explain why. Most of these shots are for flu or COVID, but as the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. This dynamic drives a phenomena called antigenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine. Millions of people, maybe even you or someone you know, caught the omicron variant despite being vaccinated. That's because a single mutation can make mRNA vaccines ineffective. The same risk applies to flu. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. That's why after extensive review, BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions. Thank you. Produced by the U. S. Department of Health and Human Services.

On the topic of the effectiveness of vaccines in controlling the epidemic, the speaker disagrees with the authorities. They state that vaccines do not control the spread of the virus, as countries with higher vaccination rates also have higher case numbers. They suggest that there may be a scientific phenomenon where the number of infection cases increases within 15 days to three weeks after vaccination. This phenomenon, related to facilitating antibodies, has not been sufficiently analyzed or studied in epidemiology. The speaker is Professor Raoul.

The discussion centers on a concerning viral evolution where mutations are no longer restricted to the spike protein. Speaker 0 argues that this indicates enhanced activity of cytotoxic T lymphocytes (CTLs) to diminish viral infectiousness, and that CTL activity is responsible for the decline of T cells that in turn boost non-neutralizing antibodies that prevent virulence. Based on this, Speaker 0 has been predicting that the evolution would inevitably lead to the emergence of a highly virulent variant that would cause waves of hospitalization and severe disease, even in highly vaccinated countries. The claim emphasizes that such waves would occur specifically in countries with high vaccination coverage. Speaker 1 seeks clarification, asking if what is coming is essentially “act two” with more people infected and potentially more deaths, and requests a quantifiable estimate. Speaker 0 acknowledges the request but resists providing exact figures, stating it is not due to fear of numbers but because it would be inappropriate to preface the prediction with precise statistics. He describes the anticipated outcome as “something completely, completely unprecedented in terms of the magnitude of the wave of morbidity and and, unfortunately, mortality that we will see.” When pressed again for quantification, Speaker 0 references observed data from highly vaccinated populations, noting that outcomes depend on age, vaccine coverage, and the speed of vaccination. He cautions that he would not be surprised if the situation leads to a “serious decimation of the population” in certain groups, with estimates suggesting potential impacts “in some populations, maybe up to thirty, forty percent.” In summary, the speakers describe a scenario where non-spike mutations suggest enhanced CTL-driven changes in infectiousness and immune response, forecast the emergence of a highly virulent variant capable of causing waves of severe disease even in highly vaccinated countries, and project the possibility of substantial morbidity and mortality in the coming waves, with some populations facing as much as 30–40 percent impact.

Immunologist Dr. Geert van den Bosch believes that the emergence of the Omrakhan variant will be remembered as a significant moment in history. He criticizes the naive belief that technology can control biology and expresses concern over the increasing rate of infection transmission despite vaccination efforts. Dr. van den Bosch theorizes that the virus may become more virulent and cause more disease among vaccinated individuals. This risk is also highlighted by the late Professor Luca Montagnier, who warned that using this type of vaccine during a pandemic could lead to the emergence of more infectious variants. Both experts caution against the potential consequences of these vaccines.

Speaker 0 and Speaker 1 repeatedly describe the virus as actively targeting unvaccinated people. They state, “If you are unvaccinated and the virus comes into your community, the virus will hunt you out. The virus hunts down the unvaccinated,” and insist, “The virus will find the unvaccinated. That’s what they all say. And it’s a virus that will find you if you’re not vaccinated.” They emphasize that “the virus is literally finding unvaccinated people” and that “the virus will find you” if you remain unvaccinated, especially when you are in circulation. The speakers highlight the Delta variant as particularly dangerous, saying, “The Delta variant of COVID nineteen has the potential to spread through an unvaccinated community like wildfire,” and describing Delta as “so aggressive,” asserting that “If you are unvaccinated, it’s gonna find you,” and reiterating, “Delta is finding the unvaccinated. The Delta variant will find you. If you’re not vaccinated, it will find you.” They argue the risk is not confined to crowded urban areas but “tends to find places that are under vaccinated.” The virus, they say, “does not just move to city centers. It finds the unvaccinated wherever they are.” They illustrate this with a hypothetical: “you might live in the middle of the desert, but it can still find you.” The claim is that the virus “is looking for you” among those who are unvaccinated, specifically mentioning people who are either unvaccinated or “have only had one jab and are not fully protected.” They further state that “the virus does seem to be finding older people who have not received that third dose.” The overarching claim is that “we’ll ultimately find just about everybody,” underscoring that the danger persists across different demographics and vaccination statuses. They illustrate this with a concluding anecdote: “these three people, two of them weren’t vaccinated. One had just had the first dose. The virus was found.”

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

YouTube censorship is discussed, with the speaker expressing concern about the suppression of their videos. The speaker, a doctor and university lecturer, argues that genetic vaccines can lead to the emergence of recombinant viruses. They explain that coronavirus' main method of evading the immune system is recombination, not mutation. The speaker personally chooses not to get vaccinated, believing it is a collective responsibility. They highlight that 80% of virus carriers are asymptomatic and argue that if the virus were truly deadly, the impact would be much worse. They caution against mass vaccination with vaccines that allow the virus to circulate, as it could lead to the selection of more pathogenic strains. The speaker emphasizes the importance of choice in vaccination, particularly for vulnerable individuals.

The speaker discusses the increase in COVID-19 cases and deaths after mass vaccination. They claim that the vaccines have created new variants of the virus and that the antibodies produced by the vaccines actually make the infection stronger. They argue that the new variants are a result of the selection of antibodies through vaccination. The speaker questions the decision to vaccinate during an ongoing epidemic and suggests that there are alternative treatments available.

The speakers discuss the impact of mass vaccination on the spread of COVID-19. They argue that the vaccination campaign has led to an increase in cases and deaths, particularly among young people with blood clotting issues. They claim that the variants of the virus are a result of the antibodies produced by the vaccine, which either kill the virus or force it to mutate. They also suggest that the antibodies created by the vaccine actually facilitate infection. The speakers criticize the decision to vaccinate during an ongoing epidemic and argue that the new variants are a result of the selection process caused by vaccination.